Specialty Enzymes Market: Trends, Growth and Forecast to 2025

by Mit K. SEO

The report "Specialty Enzymes Market by Type (Carbohydrases, Proteases, Lipases, Polymerases & Nucleases, and Other enzymes), Source, Application (pharmaceuticals, Research & Biotechnology, Diagnostics, and Biocatalysts), Form, and Region - Global Forecast to 2025" According to MarketsandMarkets, the specialty enzymes market is estimated to be valued at USD 4.4 billion in 2019 and is projected to reach USD 6.6 billion by 2025, recording a CAGR of 6.9% in terms of value. The growing concerns about the enzyme quality in pharmaceuticals & diagnostics and rise in demand for non-harmful biological catalysts are factors that are projected to drive the growth of the specialty enzymes market, globally.

Download PDF brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=21682828

Market Dynamics

Drivers

• Rise In Demand For Non-Harmful Biological Catalysts In Pharmaceuticals & Diagnostics

Restraints

• Lack Of Harmonization In The Regulatory Framework

• High Adoption Costs Involved For Small & Medium Enterprises

Opportunities

• Alternative To Chemical Catalysts

• Technological Innovations And Wide Industry Scope

• Launching Enzymes With Long Shelf Life

Challenges

• High Raw Material Costs Limiting Enzyme Usage

• Concern Over Quality Of Enzymes Used In Pharmaceuticals & Diagnostics

Scope of the report

By Type

Carbohydrases

Amylases
Cellulases
Other carbohydrases

Proteases
Lipases
Polymerases & nucleases
Other enzymes

By Source

Microorganisms
Plants
Animals

By Application

Pharmaceuticals
Research & biotechnology
Diagnostics
Biocatalysts

By Form

Liquid
Dry

By Region

North America
Europe
Asia Pacific
Rest of the World (RoW)

Brazil
Argentina
South Africa
Others in RoW

Request for Customization: https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=21682828

The North American region dominated the specialty enzymes market with a market share of 48.8% in 2018, whereas Asia Pacific is projected to witness the highest growth rate.

The specialty enzymes market in North America is dominating due to the increasing demand for enzymes in specialty applications. Technological innovations in machinery, optimization of production, logistics, and globalization of business have made the pharmaceutical industry one of the essential sectors in the North America region. However, the shift of industrial operations from developed regions, such as North America and Europe to Asia Pacific, has further contributed to the growth of the specialty enzymes market in Asia Pacific region. The use of specialty enzymes in biotechnology advancements such as drug cloning, transgenic organisms, and gene modification has been fueling the market in Asia Pacific. Furthermore, the European consumers have shown an inclination toward clean-label and organic products. This has enabled manufacturers to consider organic ingredients as key components of the products. Due to this, the specialty enzymes market in the European region is led by the growing focus on the production of pharmaceutical products, owing to the functional benefits of enzymes.

This report includes a study on the marketing and development strategies, along with the product portfolios of leading companies. It consists of profiles of leading companies, such as BASF (Germany), Novozymes (Denmark), Roche Holding (Switzerland), DuPont (US), Codexis (US), Dyadic International (US), Advanced Enzymes (India), Amano Enzymes (Japan), Sanofi (France), Biocatalysts (UK), Enzyme Supplies (UK), BBI Solutions (UK), Specialty Enzymes & Probiotics (US), Amicogen (South Korea), Antozyme Biotech (India), Enzyme Development Corporation (US), Nagase & Co. Ltd. (Japan), Sekisui Diagnostics (US), Merck (Germany), and Biovet (Bulgaria).